Skip to main content
SpringerLink
Log in

Globular adiponectin inhibits leptin-stimulated esophageal adenocarcinoma cell proliferation via adiponectin receptor 2-mediated suppression of UHRF1

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Esophageal adenocarcinoma (EAC) is one of the most common malignancies in the world which is associated the increased prevalence of obesity. In the context of obesity, leptin can directly contribute to progression of EAC. Adiponectin inhibits leptin-induced oncogenic signaling in EAC cells. However, the exact molecular mechanisms linking obesity, adipokines, and EAC remain far from completely understood. In the present study, we tested the role of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) in adiponectin-induced protective effects against leptin-induced EAC cell proliferation. We found that globular adiponectin (gAD) significantly inhibited leptin-induced increase of cell proliferation and decrease of apoptosis in OE 19 cells. Moreover, leptin-induced increase of UHRF1 expression was suppressed by gAD. Compared with normal controls, UHRF1 expression was markedly increased in EAC tissues and cell lines. Silence of UHRF1 increased the expression of cleaved caspase 3 and 9 and Bax, reduced the expression of Bcl-2, promoted apoptosis, and inhibited cell proliferation in OE 19 cells. Overexpression of UHRF1 significantly blocked gAD-induced decrease of cell proliferation and increase of apoptosis in leptin-treated cells. Silence of adiponectin receptor 1/2 (AdipoR1/2) could inhibit gAD-induced decrease of cell proliferation and increase of apoptosis in leptin-treated cells. Silence of AdipoR2, but not AdipoR1, suppressed gAD-induced decrease of UHRF1 expression in leptin-treated cells. The results indicated that gAD inhibited the prooncogenic effects of leptin via AdipoR2-mediated suppression of UHRF1. Our study provides novel insights into the role of UHRF1 in the development of EAC and the mechanism of antitumor effect of gAD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Pennathur A, Gibson MK, Jobe BA, Luketich JD (2013) Oesophageal carcinoma. Lancet 381:400–412. doi:10.1016/s0140-6736(12)60643-6

    Article  PubMed  Google Scholar 

  2. Pohl H, Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97:142–146. doi:10.1093/jnci/dji024

    Article  PubMed  Google Scholar 

  3. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106–130

    Article  PubMed  Google Scholar 

  4. Anaparthy R, Sharma P (2014) Progression of Barrett oesophagus: role of endoscopic and histological predictors. Nat Rev Gastroenterol Hepatol 11:525–534. doi:10.1038/nrgastro.2014.69

    Article  PubMed  Google Scholar 

  5. Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB (2003) Temporal trends (1973–1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol 98:1627–1633. doi:10.1111/j.1572-0241.2003.07454.x

    PubMed  Google Scholar 

  6. Li X, Galipeau PC, Paulson TG, Sanchez CA, Arnaudo J, Liu K, Sather CL, Kostadinov RL, Odze RD, Kuhner MK, Maley CC, Self SG, Vaughan TL, Blount PL and Reid BJ (2014) Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett’s esophagus. Cancer Prev Res (Phila) 7: 114–127. doi:10.1158/1940-6207.capr-13-0289

    Article  Google Scholar 

  7. Lagergren J, Bergstrom R, Nyren O (1999) Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 130:883–890

    Article  CAS  PubMed  Google Scholar 

  8. Buttar NS, Wang KK (2004) Mechanisms of disease: Carcinogenesis in Barrett’s esophagus. Nat Clin Pract Gastroenterol Hepatol 1:106–112. doi:10.1038/ncpgasthep0057

    Article  PubMed  Google Scholar 

  9. Carr JS, Zafar SF, Saba N, Khuri FR, El-Rayes BF (2013) Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma. J Gastrointest Cancer 44:143–151. doi:10.1007/s12029-013-9480-z

    Article  PubMed  Google Scholar 

  10. Nie S, Chen T, Yang X, Huai P, Lu M (2014) Association of Helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis. Dis Esophagus 27:645–653. doi:10.1111/dote.12194

    Article  CAS  PubMed  Google Scholar 

  11. Beales IL, Garcia-Morales C, Ogunwobi OO and Mutungi G (2014) Adiponectin inhibits leptin-induced oncogenic signalling in oesophageal cancer cells by activation of PTP1B. Mol Cell Endocrinol 382:150–158. doi:10.1016/j.mce.2013.08.013

    Article  CAS  PubMed  Google Scholar 

  12. Mokrowiecka A, Sokolowska M, Luczak E, Dudojc M, Wieczfinska J, Kacprzak D, Wierzchniewska-Lawska A, Pawliczak R, Malecka-Panas E (2013) Adiponectin and leptin receptors expression in Barrett’s esophagus and normal squamous epithelium in relation to central obesity status. J Physiol Pharmacol 64:193–199

    CAS  PubMed  Google Scholar 

  13. Thompson OM, Beresford SA, Kirk EA, Bronner MP, Vaughan TL (2010) Serum leptin and adiponectin levels and risk of Barrett’s esophagus and intestinal metaplasia of the gastroesophageal junction. Obesity (Silver Spring) 18:2204–2211. doi:10.1038/oby.2009.508

    Article  CAS  Google Scholar 

  14. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292–295. doi:10.1056/nejm199602013340503

    Article  CAS  PubMed  Google Scholar 

  15. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394:897–901. doi:10.1038/29795

    Article  CAS  PubMed  Google Scholar 

  16. Tsuchiya T, Shimizu H, Horie T, Mori M (1999) Expression of leptin receptor in lung: leptin as a growth factor. Eur J Pharmacol 365:273–279

    Article  CAS  PubMed  Google Scholar 

  17. Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP (2001) Leptin is a growth factor for colonic epithelial cells. Gastroenterology 121:79–90

    Article  CAS  PubMed  Google Scholar 

  18. Somasundar P, Frankenberry KA, Skinner H, Vedula G, McFadden DW, Riggs D, Jackson B, Vangilder R, Hileman SM, Vona-Davis LC (2004) Prostate cancer cell proliferation is influenced by leptin. J Surg Res 118:71–82. doi:10.1016/j.jss.2004.01.017

    Article  CAS  PubMed  Google Scholar 

  19. Howard JM, Cathcart MC, Healy L, Beddy P, Muldoon C, Pidgeon GP, Reynolds JV (2014) Leptin and adiponectin receptor expression in oesophageal cancer. Br J Surg 101:643–652. doi:10.1002/bjs.9469

    Article  CAS  PubMed  Google Scholar 

  20. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79–83

    Article  CAS  PubMed  Google Scholar 

  21. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762–769. doi:10.1038/nature01705

    Article  CAS  PubMed  Google Scholar 

  22. Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H (2005) Plasma adiponectin and gastric cancer. Clin Cancer Res 11:466–472

    Article  CAS  PubMed  Google Scholar 

  23. Dalamaga M, Diakopoulos KN, Mantzoros CS (2012) The role of adiponectin in cancer: a review of current evidence. Endocr Rev 33:547–594. doi:10.1210/er.2011-1015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Petridou E, Mantzoros C, Dessypris N, Koukoulomatis P, Addy C, Voulgaris Z, Chrousos G, Trichopoulos D (2003) Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 88:993–997. doi:10.1210/jc.2002-021209

    Article  CAS  PubMed  Google Scholar 

  25. Li H, Stampfer MJ, Mucci L, Rifai N, Qiu W, Kurth T, Ma J (2010) A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival. Clin Chem 56:34–43. doi:10.1373/clinchem.2009.133272

    Article  CAS  PubMed  Google Scholar 

  26. Ogunwobi OO, Beales IL (2008) Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol 285:43–50. doi:10.1016/j.mce.2008.01.023

    Article  CAS  PubMed  Google Scholar 

  27. Vucenik I, Stains JP (2012) Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann N Y Acad Sci 1271:37–43. doi:10.1111/j.1749-6632.2012.06750.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Lagergren J (2011) Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol 8:340–347. doi:10.1038/nrgastro.2011.73

    Article  PubMed  Google Scholar 

  29. Hopfner R, Mousli M, Jeltsch JM, Voulgaris A, Lutz Y, Marin C, Bellocq JP, Oudet P, Bronner C (2000) ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression. Cancer Res 60:121–128

    CAS  PubMed  Google Scholar 

  30. Sharif J, Muto M, Takebayashi S, Suetake I, Iwamatsu A, Endo TA, Shinga J, Mizutani-Koseki Y, Toyoda T, Okamura K, Tajima S, Mitsuya K, Okano M, Koseki H (2007) The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 450:908–912. doi:10.1038/nature06397

    Article  CAS  PubMed  Google Scholar 

  31. Bostick M, Kim JK, Esteve PO, Clark A, Pradhan S, Jacobsen SE (2007) UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 317:1760–1764. doi:10.1126/science.1147939

    Article  CAS  PubMed  Google Scholar 

  32. Unoki M, Daigo Y, Koinuma J, Tsuchiya E, Hamamoto R, Nakamura Y (2010) UHRF1 is a novel diagnostic marker of lung cancer. Br J Cancer 103:217–222. doi:10.1038/sj.bjc.6605717

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Sabatino L, Fucci A, Pancione M, Carafa V, Nebbioso A, Pistore C, Babbio F, Votino C, Laudanna C, Ceccarelli M, Altucci L, Bonapace IM, Colantuoni V (2012) UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression. Oncogene 31:5061–5072. doi:10.1038/onc.2012.3

    Article  CAS  PubMed  Google Scholar 

  34. Mudbhary R, Hoshida Y, Chernyavskaya Y, Jacob V, Villanueva A, Fiel MI, Chen X, Kojima K, Thung S, Bronson RT, Lachenmayer A, Revill K, Alsinet C, Sachidanandam R, Desai A, SenBanerjee S, Ukomadu C, Llovet JM, Sadler KC (2014) UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma. Cancer Cell 25:196–209. doi:10.1016/j.ccr.2014.01.003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Arima Y, Hirota T, Bronner C, Mousli M, Fujiwara T, Niwa S, Ishikawa H, Saya H (2004) Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes Cells 9:131–142

    Article  CAS  PubMed  Google Scholar 

  36. Tien AL, Senbanerjee S, Kulkarni A, Mudbhary R, Goudreau B, Ganesan S, Sadler KC, Ukomadu C (2011) UHRF1 depletion causes a G2/M arrest, activation of DNA damage response and apoptosis. Biochem J 435:175–185. doi:10.1042/bj20100840

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Muto M, Kanari Y, Kubo E, Takabe T, Kurihara T, Fujimori A, Tatsumi K (2002) Targeted disruption of Np95 gene renders murine embryonic stem cells hypersensitive to DNA damaging agents and DNA replication blocks. J Biol Chem 277:34549–34555. doi:10.1074/jbc.M205189200

    Article  CAS  PubMed  Google Scholar 

  38. Ge TT, Yang M, Chen Z, Lou G, Gu T (2016) UHRF1 gene silencing inhibits cell proliferation and promotes cell apoptosis in human cervical squamous cell carcinoma CaSki cells. J Ovarian Res 9:42. doi:10.1186/s13048-016-0253-8

    Article  PubMed  PubMed Central  Google Scholar 

  39. Wang BC, Lin GH, Wang B, Yan M, He B, Zhang W, Yang AK, Long ZJ, Liu Q (2016) UHRF1 suppression promotes cell differentiation and reduces inflammatory reaction in anaplastic thyroid cancer. Oncotarget. doi:10.18632/oncotarget.10674

    Google Scholar 

  40. Nakamura K, Baba Y, Kosumi K, Harada K, Shigaki H, Miyake K, Kiyozumi Y, Ohuchi M, Kurashige J, Ishimoto T, Iwatsuki M, Sakamoto Y, Yoshida N, Watanabe M, Nakao M, Baba H (2016) UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma. Oncotarget. doi:10.18632/oncotarget.11067

    Google Scholar 

  41. Yang C, Wang Y, Zhang F, Sun G, Li C, Jing S, Liu Q, Cheng Y (2013) Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma. Mol Biol Rep 40:5225–5235. doi:10.1007/s11033-013-2559-6

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, The Second Affiliated Hospital of Xi’an Jiaotong University, No. 157, Xi Wu Road, Xi’an, 710004, Shaanxi, China

    Jun Wang, Yan Cheng, Xiaoran Yin, Jie Wu, Yumei Luo, Jing Wu, Jia Di, Dong Liu, Rong Zhang & Jun Zhang

  2. Department of Gastroenterology, Xi’an Hospital of Traditional Chinese Medicine, No. 69, Feng Eighth Road, Xi’an, 710021, Shaanxi, China

    Jun Wang & Yahui Huang

Authors
  1. Jun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yan Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaoran Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jie Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yumei Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jing Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jia Di
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yahui Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Rong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun Zhang.

Ethics declarations

Conflict of interest

The authors declare none conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, J., Cheng, Y., Yin, X. et al. Globular adiponectin inhibits leptin-stimulated esophageal adenocarcinoma cell proliferation via adiponectin receptor 2-mediated suppression of UHRF1. Mol Cell Biochem 431, 103–112 (2017). https://doi.org/10.1007/s11010-017-2980-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-017-2980-6

Keywords

Search

Navigation